All News #Library
Biotech
ExeVir Announces Michael Garrett as New Chief Executive Officer
18 Nov 2024 //
GLOBENEWSWIRE
ExeVir Bio presents promising XVR013m data at ID Week 2024
17 Oct 2024 //
GLOBENEWSWIRE
ExeVir Bio: XVR013m Potent Against SARS-CoV-2 Variant JN1
04 Jun 2024 //
GLOBENEWSWIRE
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012
15 Jan 2024 //
GLOBENEWSWIRE
ExeVir Bio and VIB Announce Data on a New Therapy for Treatment for COVID-19
13 Mar 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support